We found that the high expression of ENO1 in bladder tumor samples predicted a worse survival rate, and the correlation analysis showed that there was a significant positive correlation between the expression of FTO and IGF2BP3, suggesting that ENO1 plays a key role in the malignant progression group (cluster 1) of BLCA. Here, ENO1 is linked to bladder transitional cell carcinoma.